Host Dr. Martin A. Samuels, neurologist-in-chief and chairman of the department of neurology at Brigham and Women's Hospital, and professor of neurology at Harvard Medical School, answers your questions about promising therapies for ALS, the role of exercise for Parkinson's disease patients, sleep apnea, and more. If you are a healthcare professional and have a question you want to ask the neurologist, email it to inspired@reachmd.com.
Ask the Neurologist: Dr. Samuels Answers Your Questions

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Host Dr. Martin A. Samuels, neurologist-in-chief and chairman of the department of neurology at Brigham and Women's Hospital, and professor of neurology at Harvard Medical School, answers your questions about promising therapies for ALS, the role of exercise for Parkinson's disease patients, sleep apnea, and more. If you are a healthcare professional and have a question you want to ask the neurologist, email it to inspired@reachmd.com.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
Integrating Guideline Directed Medical Therapy for Patients with CKD and T2D
Level Up Your Skills: Tailoring Management of HF
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
FINE-HEART Pooled Analysis
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?